Coalition Letter Calling on the Senate Not to End the Current Development of Quality Standards for Biologics Byeditor July 23, 2019September 18, 2019
THE HILL: Public Quality Standards for Biologic Drugs Promote Transparency and Competition; Don’t Get Rid of Them ByLiam Sigaud July 23, 2019August 15, 2019
Novel Financing Approaches are Needed to Capitalize on Life-Saving Gene Therapies Byeditor February 12, 2019February 11, 2019
Coalition Sends Letter to FDA: Foster Biosimilar Competition and Reduce Costs Byeditor September 21, 2018September 21, 2018
Lab Developed Tests Can Deliver Consumer Safety and Benefits ByAlan Daley March 28, 2018February 28, 2024
Sunshine State News: Hearing More Congressional Regulation? BySteve Pociask May 17, 2017February 28, 2024
ACI Signs Coalition Letter To Prevent FDA Regulations on Amplification Devices BySteve Pociask May 8, 2017May 9, 2017
Real Clear Health: Counterfeits Kill: Stronger Law Enforcement Needed BySteve Pociask October 7, 2016February 14, 2019
